Psilocybin & PTSD
Explore mushroom research and guides on psilocybin & ptsd.
How Psilocybin Therapy Approaches Trauma Differently
Psilocybin therapy doesn't require reliving trauma. New qualitative trial data and brain imaging studies explain how it approaches trauma so differently.
Psilocybin and Fear Extinction: The Neuroscience of Trauma Release
In 2025, Nature Neuroscience documented psilocybin rebalancing fear circuits at the single-neuron level. Here's the full neuroscience of psilocybin fear extinction — and where the evidence stops.
Psilocybin for Moral Injury: What Standard Treatment Misses
Moral injury creates guilt and shame, not fear. This piece explains why psilocybin's mechanism may address moral injury where prolonged exposure cannot.
Psilocybin for PTSD: Safety and Tolerability Data
The only published psilocybin PTSD trial reports headache (50%), nausea (36%), crying (27%), zero serious adverse events, and 91.4% same-day resolution.
Psilocybin for PTSD: What the Clinical Trials Show
Psilocybin for PTSD: clinical evidence from trials, brain imaging, veterans research, and what Australia's 2023 rescheduling actually approved. Complete evidence review through 2025.
Psilocybin for Veterans with PTSD: Research and Advocacy
A 2025 pilot of 15 veterans found 47% responded at 12 weeks. Here's what the research shows about psilocybin for veteran PTSD and who's advocating for access.
Psilocybin for Veteran PTSD: The Case for Military Research
Standard PTSD treatments fail 33% to 50% of veterans. A 2025 COMP360 trial and the Ellis veteran pilot study explain why psilocybin research may close that gap.